Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.

Progress in neuro-psychopharmacology & biological psychiatry - 30 Mar 2011

Mick Eric, McGough James J, Middleton Frank A, Neale Benjamin, Faraone Stephen V

Abstract excerpt

OBJECTIVE: We conducted a genome-wide association study of blood pressure in an open-label study of the methylphenidate transdermal system (MTS) for the treatment of attention-deficit/hyperactivity disorder (ADHD). METHOD: Genotyping was conducted with the Affymetrix Genome-Wide Human SNP Array 6...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Cutaneous
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Pressure

Share to Central Nervous System Stimulants

Share to Drug Interactions

Share to Hypertension

Share to Methylphenidate

Share to Sodium-Calcium Exchanger

Source

Identifiers

PMID: 21130132
DOI: 10.1016/j.pnpbp.2010.11.037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21130132-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.PMID 21130132Read ↗

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.Semantic proximity Read ↗

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Semantic proximity Read ↗

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations.Semantic proximity Read ↗

Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.Semantic proximity Read ↗

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Semantic proximity Read ↗

Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.Semantic proximity Read ↗

Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.Semantic proximity Read ↗

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.